February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 05, 2025

Microplastics Found in Human Brain Tissue

"Brain samples, all derived from the frontal cortex, exhibited substantially higher concentrations of MNPs than liver or kidney."

Conexiant

July 14, 2023

Scientists Discover a Deadly Brain Cancer’s Hidden Weakness

The difficult-to-treat brain cancer glioblastoma steals a person’s mental faculties as it spreads, yet the tumor’s insidious ability to infiltrate distant networks in the brain could also prove its undoing.

UCSF MedConnection

July 25, 2023

Origins of Glioma Brain Cancer Found to be in the Epigenome

While cancers often originate from mutations and other alterations of cells' DNA, researchers in the Bernstein Laboratory at Dana-Farber and the Broad Institute of MIT and Harvard have found that gliomas – incurable brain tumors – can arise due to changes in the epigenome, the collection of compounds that are deposited on DNA and alter gene activity without changing the sequence of DNA itself.

Dana-Farber

June 09, 2023

"Frontiers of Medical Research: Brain Science,” a Supplement from Science and the Icahn School of Medicine at Mount Sinai

This collection of eight articles brings together neuroscientists, psychiatrists, and geneticists, among others, to unravel the pathophysiology of brain dysfunction.

Mount Sinai New York

August 07, 2024

FDA Approves Voranigo for Grade 2 IDH-Mutant Glioma

The FDA's approval of voranigo marks a significant milestone as it becomes the first drug approved in the U.S. for the treatment of Grade 2 IDH-mutant glioma, a type of brain tumor, with promising results in a late-stage clinical trial.

Reuters

September 03, 2024

Mobile Phones Not Linked to Brain Cancer

WHO and global health bodies called for re-evaluation of the 2011 cancer risk classification.

Reuters

September 18, 2024

Do Hydrocephalus Shunts Pose Less Pregnancy Risk Than Once Thought?

A 2024 study of 85 pregnancies found no shunt malfunctions during pregnancy and only a 5.9% postpartum revision rate, contradicting decades of data on shunt failure risks for pregnant women.

Conexiant

November 06, 2024

Weekend Warriors: New Hope for Busy Docs

Almost half of surgeons miss exercise guidelines, but research shows "weekend warriors" achieve similar cardiovascular benefits to those who exercise daily.

Conexiant